Resurrection of Oral Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: A Historical Account From Bedside to Bench to Bedside.

Kumana CR, Mak R, Kwong YL, Gill H

Open source

DOI
10.3389/fonc.2020.01294
Published
2020
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2020.01294,
  title = {Resurrection of Oral Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: A Historical Account From Bedside to Bench to Bedside.},
  author = {Kumana CR and Mak R and Kwong YL and Gill H},
  year = {2020},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2020.01294},
  url = {https://doi.org/10.3389/fonc.2020.01294}
}

RIS

TY  - JOUR
TI  - Resurrection of Oral Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: A Historical Account From Bedside to Bench to Bedside.
AU  - Kumana CR
AU  - Mak R
AU  - Kwong YL
AU  - Gill H
PY  - 2020
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2020.01294
UR  - https://doi.org/10.3389/fonc.2020.01294
ER  - 

APA

CR, K., R, M., YL, K., & H, G. (2020). Resurrection of Oral Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: A Historical Account From Bedside to Bench to Bedside.. Frontiers in oncology. https://doi.org/10.3389/fonc.2020.01294

Source records